% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Liermann:170073,
author = {J. Liermann$^*$ and P. Naumann and F. Weykamp and P.
Hoegen$^*$ and J. Debus$^*$ and K. Herfarth$^*$},
title = {{E}ffectiveness of {C}arbon {I}on {R}adiation in {L}ocally
{A}dvanced {P}ancreatic {C}ancer.},
journal = {Frontiers in oncology},
volume = {11},
issn = {2234-943X},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {DKFZ-2021-01739},
pages = {708884},
year = {2021},
abstract = {Effective treatment strategies for unresectable locally
advanced pancreatic cancer (LAPC) patients are eagerly
warranted. Recently, convincing oncological outcomes were
demonstrated by carbon ion radiotherapy. Nevertheless, there
is a lack of evidence for this modern radiation technique
due to the limited number of carbon ion facilities
worldwide. Here, we analyze feasibility and efficacy of
carbon ion radiotherapy in the management of LAPC at
Heidelberg Ion Beam Therapy Center (HIT).Between 2015 and
2020, 21 LAPC patients were irradiated with carbon ions with
a total dose of 48 Gy (RBE) in single doses of 4 Gy (RBE).
Three patients $(14\%)$ were treated with concomitant
chemotherapy with gemcitabine 300 mg/m2 body surface weekly.
Toxicity rates were extracted from the charts. Overall
survival, progression free survival, local control, and
locoregional control were evaluated using Kaplan-Meier
estimates.One patient developed ascites CTCAE grade III
during radiotherapy, which was related to a later
histologically confirmed metachronous peritoneal
carcinomatosis. No further higher-graded toxicity could be
observed. The most common symptoms were nausea and abdominal
pain. After a median estimated follow-up time of 19.1
months, the median progression free survival was 3.7 months,
and the median overall survival was 11.9 months. The
estimated 1-year local control and locoregional control
rates were 89 and $84\%,$ respectively.Carbon ion
radiotherapy of LAPC patients is safely feasible. Local
tumor control rates were high. Nevertheless, compared to
historical data, an overall survival improvement could not
be observed. This could be explained by the poor prognosis
of the selected underlying patients that mostly did not
respond to prior chemotherapy as well as the early and
frequent emergence of distant metastases that demonstrate
the necessity of additional chemotherapy in further
studies.},
keywords = {carbon ion radiotherapy (Other) / heavy ion (Other) /
irradiation (Other) / locally advanced pancreatic cancer
(Other) / pancreatic cancer (Other) / particle therapy
(Other)},
cin = {E050 / HD01},
ddc = {610},
cid = {I:(DE-He78)E050-20160331 / I:(DE-He78)HD01-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34336696},
pmc = {pmc:PMC8318663},
doi = {10.3389/fonc.2021.708884},
url = {https://inrepo02.dkfz.de/record/170073},
}